This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) rallied 4.49% to $384.32 Friday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 1.97% to 6,932.30 and the Dow Jones Industrial Average rising 2.47% to 50,115.67.
This was the stock's third consecutive day of gains.
Amgen Inc. hit a new 52-week high, surpassing its previous peak of $374.90, which the company reached on February 5th.
The stock outperformed some of its competitors Friday, as Johnson &amp; Johnson (JNJ) rose 0.93% to $239.99, Pfizer Inc. (PFE) rose 2.76% to $27.22, and AbbVie Inc. (ABBV) rose 2.01% to $223.43.
Trading volume (3.8 M) eclipsed its 50-day average volume of 2.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 6, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
02-06-26 1635ET

TBXU

Amgen Inc. (AMGN) shares rose 4.49% to $384.32, marking a strong trading day as the S&P 500 and Dow Jones also gained. This is Amgen's third consecutive day of gains, reaching a new 52-week high, surpassing its previous peak of $374.90. Competitors like Johnson & Johnson, Pfizer, and AbbVie saw smaller increases. Trading volume was 3.8 million, above the 50-day average of 2.9 million.

- Shares of Amgen Inc. (AMGN) increased by 4.49% to $384.32, marking the third consecutive day of gains.  
- The stock reached a new 52-week high, surpassing its previous peak of $374.90, amidst an overall strong trading session for the market.  
- Trading volume for Amgen was 3.8 million, exceeding its 50-day average of 2.9 million, while the S&P 500 rose 1.97% and the Dow Jones increased by 2.47%.

Dow Jones

Pfizer

SPDR S&P Biotech

Direxion Daily Biotech Top 5 Bull 2X ETF

First Trust NYSE Arca Biotech Index Fd

Abbvie

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

VG Health

Amgen

Health Care Select Sector SPDR

Proshares Ultra Nasdaq Biotech

VanEck Biotech ETF

Invesco Biotechnology & Genome ETF

iShares Global Healthcare

ALPS Medical Breakthrough

iShares Biotechnology ETF

Ark Genomic Revolution ETF

Johnson & Johnson

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day